A Clinical Trial to Prevent the Complications of Insulin Resistance (Including Type-2 Diabetes)

Phase 2

Completed

• Conditions: Diabetes Mellitus; Insulin Resistance

• Registration Number: NCT00015626
• Lead Sponsor: National Center for Research Resources (NCRR)

Brief Summary

The goal of this study is to aggressively treat insulin resistance and its clinical manifestations when they first appear in childhood, and to prevent the subsequent progression towards impaired glucose tolerance and type-2 diabetes. In the process of this clinical trial, we will learn more about the early manifestations of insulin resistance, its treatment, and its relationship to obesity and type-2 diabetes through parallel in-vivo and in-vitro studies.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2001-04-24
• Study First Submitted QC: 2001-04-25
• Study First Posted: 2001-04-26
• Status Verified: 2003-12
• Last Update Submitted: 2005-06-23
• Last Update Posted: 2005-06-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 300

Inclusion Criteria

Not provided

Exclusion Criteria

1. Critically ill patients, patients will congestive heart failure, renal or liver insufficiency
2. Inability to give consent.
3. History of poor compliance with physician's recommendations

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Cornell University; 🇺🇸 New York, New York, United States